Derma Sciences

Derma Sciences is a Medical Devices company specializing in the field of Advanced Wound Care. Currently their major products are Medihoney, Algicell AG, Xtrasorb wound dressing, Bioguard and Mobility1. Their newest product DSC127 - an Angiotensin Analog - is currently in Phase II Pre-Clinical trials.
Type
Public
HQ
Princeton, US
Employees
260 (est)-13%

Key People at Derma Sciences

Edward J. Quilty

Edward J. Quilty

Chairman & CEO
Srini Conjeevaram

Srini Conjeevaram

Director
John E. Yetter

John E. Yetter

CFO & Vice President of Finance

Derma Sciences Locations

Princeton, US
New York, US

Derma Sciences Metrics

Derma Sciences Summary

Market capitalization

$127 M

Closing share price

$4.75

Derma Sciences Market Value History

Derma Sciences News

Derma Sciences Company Life

You may also be interested in